PTNPalatin Technologies, Inc.

9.690USD-4.81%Mkt Cap: 17.24M $P/E: 88.09

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral sma…

Key Statistics

Company
Market Cap17.24M $
Enterprise Value7.37M $
Revenue (TTM)12.88M $
Gross Profit0 $
Net Income (TTM)-17.31M $
Revenue/Share6.277 USD
Last Price9.690 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6960775020
Valuation
P/E (Trailing)88.09
P/E (Forward)-3.99
PEG1.62
EV/EBITDA-0.84
EV/Revenue0.57
P/S1.34
P/B1.63
EPS (TTM)0.11
EPS (Forward)-2.43
52W Range
5.61016% of range31.00
52W High31.00 USD
52W Low5.610 USD
Profitability
Gross Margin4.28%
Oper. Margin-40.33%
EBITDA Margin-67.93%
Profit Margin-48.50%
ROE362.30%
ROA-529.77%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-21.31M $
CapEx (TTM)
FCF Margin-106.12%
FCF Yield-79.31%
Net Debt-9.87M $
Net Debt/EBITDA1.13
Balance Sheet
Debt/Equity-0.03
Current Ratio5.04
Quick Ratio4.86
Book Value/Sh5.963 USD
Cash/Share5.710 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:50
Split DateAug 12, 2025
Analyst Consensus
Rating
Target (Mean)53.50 USD
Upside (mean)+452.1%
Target Range47.50 USD60.00 USD
$47.50+452.1% to mean$60.00
# Analysts3
Ownership
Shares Out.1.78M
Float1.49M
Insiders7.86%
Institutions50.73%
Short Interest
Short Ratio16.0d
Short % Float17.53%
Short % Out.16.67%
Shares Short296.66K
Short (prev mo.)182.62K
Technical
SMA 509.711 (-0.2%)
SMA 20015.95 (-39.3%)
Beta-0.10
S&P 52W Chg19.18%
Avg Vol (30d)17.39K
Avg Vol (10d)31.17K
Technical Indicators
RSI (14)54.6
MACD-0.0199
MACD Signal-0.4134
MACD Hist.+0.3935
BB Upper10.32 USD
BB Middle8.403 USD
BB Lower6.488 USD
BB Width45.58%
ATR (14)0.9732 USD
Vol Ratio (20d)0.23x